Stephanie W. Zitomer

Array ( [id] => 3949889 [patent_doc_number] => 05977333 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'DNA sequence encoding the myotonic dystrophy gene and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/422706 [patent_app_country] => US [patent_app_date] => 1995-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 18983 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977333.pdf [firstpage_image] =>[orig_patent_app_number] => 422706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946733 [patent_doc_number] => 05955265 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'DNA sequence encoding the myotonic dystrophy gene and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/422699 [patent_app_country] => US [patent_app_date] => 1995-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 18704 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955265.pdf [firstpage_image] =>[orig_patent_app_number] => 422699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730440 [patent_doc_number] => 05670637 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Nucleic acid ligands' [patent_app_type] => 1 [patent_app_number] => 8/412110 [patent_app_country] => US [patent_app_date] => 1995-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 38 [patent_no_of_words] => 46760 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670637.pdf [firstpage_image] =>[orig_patent_app_number] => 412110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690190 [patent_doc_number] => 05696249 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Nucleic acid ligands' [patent_app_type] => 1 [patent_app_number] => 8/409442 [patent_app_country] => US [patent_app_date] => 1995-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 38 [patent_no_of_words] => 47726 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696249.pdf [firstpage_image] =>[orig_patent_app_number] => 409442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3645001 [patent_doc_number] => 05637461 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Ligands of HIV-1 TAT protein' [patent_app_type] => 1 [patent_app_number] => 8/409439 [patent_app_country] => US [patent_app_date] => 1995-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 6844 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637461.pdf [firstpage_image] =>[orig_patent_app_number] => 409439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3586535 [patent_doc_number] => 05516641 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-14 [patent_title] => 'Method for detection of specific nucleic acid sequences' [patent_app_type] => 1 [patent_app_number] => 8/401660 [patent_app_country] => US [patent_app_date] => 1995-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13392 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/516/05516641.pdf [firstpage_image] =>[orig_patent_app_number] => 401660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3854543 [patent_doc_number] => 05705337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Systematic evolution of ligands by exponential enrichment: chemi-SELEX' [patent_app_type] => 1 [patent_app_number] => 8/400440 [patent_app_country] => US [patent_app_date] => 1995-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20415 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705337.pdf [firstpage_image] =>[orig_patent_app_number] => 400440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3655211 [patent_doc_number] => 05622828 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'High-affinity oligonucleotide ligands to secretory phospholipase A2 (sPLA.sub.2)' [patent_app_type] => 1 [patent_app_number] => 8/399412 [patent_app_country] => US [patent_app_date] => 1995-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14100 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622828.pdf [firstpage_image] =>[orig_patent_app_number] => 399412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3991022 [patent_doc_number] => 05985548 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Amplification of assay reporters by nucleic acid replication' [patent_app_type] => 1 [patent_app_number] => 8/256627 [patent_app_country] => US [patent_app_date] => 1995-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22871 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985548.pdf [firstpage_image] =>[orig_patent_app_number] => 256627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3643088 [patent_doc_number] => RE035609 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Process for purifying 2\',3\'-dideoxynucleosides' [patent_app_type] => 2 [patent_app_number] => 8/385888 [patent_app_country] => US [patent_app_date] => 1995-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8901 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/035/RE035609.pdf [firstpage_image] =>[orig_patent_app_number] => 385888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3650692 [patent_doc_number] => 05639868 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'High-affinity RNA ligands for basic fibroblast growth factor' [patent_app_type] => 1 [patent_app_number] => 8/384708 [patent_app_country] => US [patent_app_date] => 1995-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22523 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639868.pdf [firstpage_image] =>[orig_patent_app_number] => 384708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4214745 [patent_doc_number] => 06087186 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Methods and apparatus for synthesizing labeled combinatorial chemistry libraries' [patent_app_type] => 1 [patent_app_number] => 8/383766 [patent_app_country] => US [patent_app_date] => 1995-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18209 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087186.pdf [firstpage_image] =>[orig_patent_app_number] => 383766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924757 [patent_doc_number] => 05876976 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Method for reducing carryover contamination in an amplification procedure' [patent_app_type] => 1 [patent_app_number] => 8/376762 [patent_app_country] => US [patent_app_date] => 1995-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 40 [patent_no_of_words] => 22799 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876976.pdf [firstpage_image] =>[orig_patent_app_number] => 376762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4176763 [patent_doc_number] => 06037152 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Method for reducing carryover contamination in an amplification procedure' [patent_app_type] => 1 [patent_app_number] => 8/376763 [patent_app_country] => US [patent_app_date] => 1995-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 22792 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037152.pdf [firstpage_image] =>[orig_patent_app_number] => 376763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619420 [patent_doc_number] => 05641629 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Spectroscopically detectable nucleic acid ligands' [patent_app_type] => 1 [patent_app_number] => 8/376329 [patent_app_country] => US [patent_app_date] => 1995-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6216 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641629.pdf [firstpage_image] =>[orig_patent_app_number] => 376329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3780586 [patent_doc_number] => 05821058 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Automated DNA sequencing technique' [patent_app_type] => 1 [patent_app_number] => 8/361176 [patent_app_country] => US [patent_app_date] => 1994-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 5120 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821058.pdf [firstpage_image] =>[orig_patent_app_number] => 361176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3780586 [patent_doc_number] => 05821058 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Automated DNA sequencing technique' [patent_app_type] => 1 [patent_app_number] => 8/361176 [patent_app_country] => US [patent_app_date] => 1994-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 5120 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821058.pdf [firstpage_image] =>[orig_patent_app_number] => 361176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3768375 [patent_doc_number] => 05756287 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'High affinity HIV integrase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/361795 [patent_app_country] => US [patent_app_date] => 1994-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10222 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756287.pdf [firstpage_image] =>[orig_patent_app_number] => 361795 [rel_patent_id] =>[rel_patent_doc_number] =>)